Answer
It is a bispecific antibody that connects BCMA-bearing myeloma cells with CD3-bearing T cells so the immune system can attack the cancer cells.
Sources for this answer
- TECVAYLI 90mg/ml solution for injection — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.